Company / Cash & Equivalents
Electromedical Technologies, Inc Cash & Equivalents History
FY2020-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$87.7K
FY2023
5-year range
$87.7K / $383.2K
FY2020-FY2023
Trend
-76.2%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $383,170 to $87,704 over the past 2 years.
Based on SEC 10-K filings.
$87,704 in FY2023 with a 3-year CAGR of -30.8%.
Declined from $383,170 to $87,704 over the past 2 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -30.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -30.8%, indicating a declining trend.
- In FY2023, cash & equivalents decreased 76.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score -40.98 (distress zone, below 1.23 threshold)
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | $87.7K | -76.2% |
| FY2022 | $368.4K | -3.8% |
| FY2021 | $383.2K | +44.6% |
| FY2020 | $264.9K | - |